EA201300882A1 - Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс (варианты), набор и лекарственное средство - Google Patents

Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс (варианты), набор и лекарственное средство

Info

Publication number
EA201300882A1
EA201300882A1 EA201300882A EA201300882A EA201300882A1 EA 201300882 A1 EA201300882 A1 EA 201300882A1 EA 201300882 A EA201300882 A EA 201300882A EA 201300882 A EA201300882 A EA 201300882A EA 201300882 A1 EA201300882 A1 EA 201300882A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sealing
constipation
fecal masses
aqueous solution
medication
Prior art date
Application number
EA201300882A
Other languages
English (en)
Other versions
EA028925B1 (ru
Inventor
Фрэнсис Моррисси
Дон Падфилд
Крис Селдон
Original Assignee
Норджин Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Норджин Бв filed Critical Норджин Бв
Publication of EA201300882A1 publication Critical patent/EA201300882A1/ru
Publication of EA028925B1 publication Critical patent/EA028925B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Изобретение относится к водным растворам, содержащим полиэтиленгликоль, для применения в качестве лекарственного средства, особенно в лечении констипации или уплотнения фекальных масс. Растворы могут быть предохранены посредством подавления роста микробных организмов. Предложены также наборы, содержащие предохраненный водный раствор и отдельную таблетку или капсулу, содержащую электролиты.
EA201300882A 2011-01-31 2012-01-31 Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс, набор и лекарственное средство (варианты) EA028925B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Publications (2)

Publication Number Publication Date
EA201300882A1 true EA201300882A1 (ru) 2014-01-30
EA028925B1 EA028925B1 (ru) 2018-01-31

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300882A EA028925B1 (ru) 2011-01-31 2012-01-31 Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс, набор и лекарственное средство (варианты)

Country Status (16)

Country Link
EP (2) EP2670391A1 (ru)
JP (2) JP2014504628A (ru)
KR (1) KR101852502B1 (ru)
CN (2) CN107260661A (ru)
AU (1) AU2012213180B2 (ru)
BR (1) BR112013019418B1 (ru)
DE (1) DE202012013349U1 (ru)
DK (1) DK2862566T3 (ru)
EA (1) EA028925B1 (ru)
ES (1) ES2914034T3 (ru)
HR (1) HRP20220691T1 (ru)
MX (1) MX360450B (ru)
PL (1) PL2862566T3 (ru)
PT (1) PT2862566T (ru)
WO (1) WO2012104617A1 (ru)
ZA (1) ZA201305342B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CA3116204C (en) 2012-09-11 2023-09-12 Norgine Bv Colon cleansing composition comprising ascorbate and peg
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
US20180318234A1 (en) * 2015-06-22 2018-11-08 Ctc Bio, Inc. Purgative composition for cleansing intestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050003021A1 (en) * 2001-10-29 2005-01-06 Takayuki Sugiyama Bowel cleansing agent
AU2004290580A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic PEG solution concentrate
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Also Published As

Publication number Publication date
MX360450B (es) 2018-11-01
HRP20220691T1 (hr) 2022-07-08
DK2862566T3 (da) 2022-05-16
CN103458874A (zh) 2013-12-18
KR20140007881A (ko) 2014-01-20
WO2012104617A1 (en) 2012-08-09
AU2012213180B2 (en) 2017-04-13
BR112013019418B1 (pt) 2022-03-29
JP6498250B2 (ja) 2019-04-10
PL2862566T3 (pl) 2022-06-20
MX2013008635A (es) 2013-11-04
EA028925B1 (ru) 2018-01-31
KR101852502B1 (ko) 2018-04-26
JP2018035181A (ja) 2018-03-08
PT2862566T (pt) 2022-06-02
BR112013019418A2 (ru) 2017-08-29
EP2670391A1 (en) 2013-12-11
CN107260661A (zh) 2017-10-20
ES2914034T3 (es) 2022-06-07
EP2862566B1 (en) 2022-03-09
NZ613401A (en) 2016-03-31
JP2014504628A (ja) 2014-02-24
DE202012013349U1 (de) 2016-06-27
EP2862566A1 (en) 2015-04-22
ZA201305342B (en) 2014-12-23

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
MA37400A1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
EA201490493A1 (ru) Пирано[3,2-d][1,3]тиазол в качестве ингибиторов гликозидазы
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA028156B9 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
GB201106743D0 (en) Novel compounds
PH12015501609A1 (en) Phenicol antibacterials
SG178952A1 (en) Chemical compounds
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
EA201390984A1 (ru) Гетероциклические соединения, подходящие для лечения дислипидемии
MY170511A (en) Colonoscopy-preparation
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
EA201001858A1 (ru) Гетероциклические производные мочевины для лечения бактериальных инфекций
EA201300882A1 (ru) Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс (варианты), набор и лекарственное средство
PH12015500185B1 (en) Azaheterocycles as bir2 and/or bir3 inhibitors
IN2015DN02109A (ru)
EA201270817A1 (ru) Соединения, обладающие антибактериальной активностью в отношении clostridium
PH12015500282A1 (en) N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
GB2491084A (en) Compounds for the treatment of renal cell carcinoma
SA515360233B1 (ar) مثبطات إنزيمات هستون ديميثيلاز